Vaxart signals $700M COVID-19 vaccine milestone path as Sanofi partnership advances and 2026 data readouts approach (OTCMKTS:VXRT)

Earnings Call InsightsVaxart signals $700M COVID-19 vaccine milestone path as Sanofi partnership advances and 2026 data readouts approachMar. 12, 2026 6:53 PM ETVaxart, Inc. (VXRT) StockAI-Generated Earnings Calls InsightsCommentsEarnings Call Insights: Vaxart (VXRT) Q4 2025 Management View Steven Lo, President and CEO, highlighted several recent milestones, including a partnership with Dynavax for the oral COVID-19 vaccine candidate and the publication of a clinical study data set for the oral norovirus v ...